Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACA | Q13085 | 4/20 | 0.42 |
| ▸ | TOP1 | P11387 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | KMO | O15229 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13458904 | 0.98 | ACACA (0.44) | ACACATOP1CYP19A1IMPDH2ESR1 | |
| SCHEMBL25850698 | 0.91 | TOP1 (0.46) | ACACATOP1ADORA3ADORA2AADORA1 | |
| SCHEMBL3698074 | 0.89 | ACACA (0.50) | ACACATOP1ADORA2AADORA1MEN1 | |
| SCHEMBL17899330 | 0.89 | ACACA (0.50) | ACACATOP1ADORA2AADORA1MEN1 | |
| SCHEMBL3358457 | 0.89 | ACACA (0.50) | ACACATOP1ADORA2AADORA1MEN1 | |
| SCHEMBL3358750 | 0.89 | ACACA (0.50) | ACACATOP1ADORA2AADORA1MEN1 | |
| SCHEMBL1745982 | 0.89 | ACACA (0.50) | ACACATOP1ADORA2AADORA1MEN1 | |
| SCHEMBL23942 | 0.88 | TOP1 (0.50) | ACACATOP1ADORA3ADORA2AADORA1 | |
| SCHEMBL23434628 | 0.87 | CYP19A1 (0.42) | ACACATOP1CYP19A1ADORA3ADORA2A | |
| SCHEMBL23434341 | 0.87 | CYP19A1 (0.42) | ACACATOP1CYP19A1ADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436341-B2 | Electronic device including phenanthroline derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-05-07 | — | — | US | disclosed |
| US-8436341-B2 | Electronic device including phenanthroline derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-05-07 | — | — | US | disclosed |
| US-8309731-B2 | Electronic device including phenanthroline derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309731-B2 | Electronic device including phenanthroline derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-20120065402-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E.I.DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120065402-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E.I.DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | disclosed |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | disclosed |
| WO-2010075379-A2 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| EP-1097981-B1 | Organic electroluminescent device | SONY CORP (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-7186469-B2 | Bathophenanthroline compound and EL device | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186469-B2 | Bathophenanthroline compound and EL device | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065402-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | PAH, AHR, TYR | ACACA 3849/4885TOP1 1475/4885CYP19A1 524/4885 |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | PAH, AHR, TYR | ACACA 3949/4885TOP1 1646/4885CYP19A1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.